What is St Jude Medical Financial Strength?
St Jude Medical has the Financial Strength Rank of 0.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
St Jude Medical's Interest Coverage for the quarter that ended in Sep. 2016 was 7.33.
St Jude Medical's debt to revenue ratio for the quarter that ended in Sep. 2016 was 0.96.
As of today, St Jude Medical's Altman Z-Score is 0.00.
Competitive Comparison of St Jude Medical's Financial Strength
For the Medical Devices subindustry, St Jude Medical's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
St Jude Medical's Financial Strength Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, St Jude Medical's Financial Strength distribution charts can be found below:
* The bar in red indicates where St Jude Medical's Financial Strength falls into.
St Jude Medical Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
St Jude Medical's Interest Expense for the
months ended in Sep. 2016 was $-39 Mil. Its Operating Income for the
months ended in Sep. 2016 was $286 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2016 was $5,403 Mil.
St Jude Medical's Interest Coverage for the quarter that ended in Sep. 2016 is
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
St Jude Medical's Debt to Revenue Ratio for the quarter that ended in Sep. 2016 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
St Jude Medical has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Jude Medical (St Jude Medical) Business Description
Traded in Other Exchanges
N/A
Address
St Jude Medical Inc was incorporated in Minnesota in 1976. It develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The Company's two segments are the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division. The Company's principal products in each business unit are as follows: Implantable Electronic Systems Division (IESD) - tachycardia implantable cardioverter defibrillator systems (ICDs), bradycardia pacemaker systems (pacemakers) and neurostimulation products (spinal cord and deep brain stimulation devices); and Cardiovascular and Ablation Technologies Division (CATD) - vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and atrial fibrillation (AF) products (electrophysiology (EP) introducers and catheters, cardiac mapping, navigation and recording systems and ablation systems). Implantable Electronic Systems Division (IESD): IESD is focused on the cardiac rhythm management and neuromodulation therapy areas. Cardiac rhythm management devices include ICDs that provide life-saving therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy (CRT) devices to save and improve the lives of patients suffering from heart failure (HF); pacemakers to help patients whose hearts beat too slowly or who suffer from other debilitating cardiac arrhythmias; leads (wires that connect devices to the heart) to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment which are used by physicians and healthcare professionals to program is cardiac rhythm management devices and analyze device data to improve patient management. Neuromodulation product offerings provide neurostimulation treatment in which an implantable device delivers electrical current directly to targeted nerve sites. The Company's commercialized neurostimulation therapies include spinal cord stimulation (SCS) for the treatment of chronic pain, deep brain stimulation (DBS) for treating the symptoms of Parkinson's disease and peripheral nerve stimulation (PNS) for the treatment of chronic migraine headache. A neurostimulation system typically consists of four components: a pulse generator that produces the electrical current and is implanted under the patient's skin; implanted leads that carry the electrical impulses to the targeted nerve sites; an external patient remote control that enables the patient to control his or her therapy within prescribed ranges; and an external clinician pro
Executives
| Jeff Fecho |
officer: VP, Global Quality |
ONE ST. JUDE MEDICAL DRIVE ST. PAUL MN 55117 |
| Philip Ebeling |
officer: VP, Chief Technology Officer |
INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416 |
| Donald Zurbay |
officer: VP Finance and CFO |
C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
| Michael A Rocca |
director |
C/O LIGAND PHARMACEUTICALS INCORPORATED, 10275 SCIENCE CENTER DRIVE, SAN DIEGO CA 92121 |
| Barbara B Hill |
director |
|
| Wendy L Yarno |
director |
|
| Stuart Essig |
director |
311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
| John C Heinmiller |
officer: Executive Vice President |
ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
| John W Brown |
director |
STRYKER CORP, 2725 FAIRFIELD ROAD, KALAMAZOO MI 49002 |
| David C Dvorak |
director |
C/O ZIMMER INC, PO BOX 708, WARSAW IN 46580 |
| Michael T Rousseau |
director, officer: Director, President and CEO |
ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117 |
| Eric S Fain |
officer: Group President |
ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN |
| Daniel J Starks |
director |
ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117 |
| Joel Becker |
officer: President, Americas |
ONE ST. JUDE MEDICAL DRIVE, ST. PAUL MN 55418 |
| Rohan Hoare |
officer: President - NMD |
100 CYBERONICS BLVD, HOUSTON TX 77058 |
St Jude Medical (St Jude Medical) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STJ has been successfully added to your